|
ARMC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.96540039587978E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.11969999833295E-08 |
| Normal-vs-Stage2 |
1.52831999999936E-05 |
| Normal-vs-Stage3 |
4.24039999780135E-08 |
| Normal-vs-Stage4 |
3.46630002479031E-09 |
| Stage1-vs-Stage2 |
6.735800E-01 |
| Stage1-vs-Stage3 |
2.382600E-01 |
| Stage1-vs-Stage4 |
4.250000E-02 |
| Stage2-vs-Stage3 |
6.861000E-01 |
| Stage2-vs-Stage4 |
2.062600E-01 |
| Stage3-vs-Stage4 |
3.317800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56379997839906E-09 |
| Normal-vs-AfricanAmerican |
4.160000E-04 |
| Normal-vs-Asian |
1.64777999999144E-05 |
| Caucasian-vs-AfricanAmerican |
7.111800E-01 |
| Caucasian-vs-Asian |
9.830400E-01 |
| AfricanAmerican-vs-Asian |
7.575200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.75410028116596E-10 |
| Normal-vs-Female |
1.16780000114503E-08 |
| Male-vs-Female |
9.354400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.81550000000197E-06 |
| Normal-vs-Age(41-60Yrs) |
1.85240045524893E-10 |
| Normal-vs-Age(61-80Yrs) |
2.95940000283323E-08 |
| Normal-vs-Age(81-100Yrs) |
9.217700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.505700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.701200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.302200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.923600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.896200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.449000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.800200E-01 |
| Classical-VS-Follicular |
1.365010E-01 |
| Classical-VS-Other |
3.139400E-01 |
| Classical-VS-Normal |
3.19120000424888E-08 |
| Tall-VS-Follicular |
6.374000E-01 |
| Tall-VS-Other |
4.787600E-01 |
| Tall-VS-Normal |
1.605020E-04 |
| Follicular-VS-Other |
6.694000E-01 |
| Follicular-VS-Normal |
2.11729999977095E-07 |
| Other-VS-Normal |
4.120400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.10730002944592E-09 |
| Normal-vs-N1 |
6.0832999970728E-08 |
| N0-vs-N1 |
4.044800E-01 |
|
|
